Today: 17 May 2026
Browse Category

NASDAQ:SIVE 3 May 2026 - 13 May 2026

Sivers Semiconductors AB Stock Jumps as MSCI Add Meets Nasdaq Listing Push

Sivers Semiconductors AB Stock Jumps as MSCI Add Meets Nasdaq Listing Push

Sivers Semiconductors shares surged 31.3% to 56.65 crowns after MSCI added the company to its Sweden small-cap index. Shareholders recently approved a private placement of 8.62 million shares at 14.50 crowns each, raising about 125 million crowns. Sivers is preparing accounts to U.S. standards as it considers a dual listing on Nasdaq New York. The company delayed its 2025 annual report to May 15.
13 May 2026
···
Sivers Semiconductors Stock Jumps 47% as Nasdaq Push and AI Optics Bet Hit Deadline Week

Sivers Semiconductors Stock Jumps 47% as Nasdaq Push and AI Optics Bet Hit Deadline Week

Sivers Semiconductors shares jumped 47.24% to SEK 55.95 in Stockholm, extending 2024 gains to over 1,200%. Shareholders face a May 5 deadline to participate in a SEK 125 million directed share issue ahead of a May 11 vote. The company delayed its 2025 annual report to May 15 to meet U.S. audit standards for a possible Nasdaq New York dual listing. Market value stood at SEK 16.59 billion.
4 May 2026
····
Sivers Semiconductors Stock Jumps 33% as Nasdaq Listing Clock Starts Ticking

Sivers Semiconductors Stock Jumps 33% as Nasdaq Listing Clock Starts Ticking

Sivers Semiconductors AB shares jumped about 33% to SEK 50.50–50.75 in Stockholm on Monday, as investors focused on a planned SEK 125 million share issue and possible U.S. listing. Shareholders face a Tuesday deadline to register for the May 11 meeting to vote on the private placement. The company delayed its annual report to May 15, citing audit work for a potential Nasdaq New York dual listing.
4 May 2026
····
Sivers Semiconductors’ Nasdaq Push Faces a May Deadline After Report Delay

Sivers Semiconductors’ Nasdaq Push Faces a May Deadline After Report Delay

Sivers Semiconductors shareholders face a May 5 deadline to give notice ahead of a May 11 vote on a 125 million crown share issue. The company delayed its 2025 annual report to May 15 for a U.S. audit uplift, as it considers a Nasdaq New York dual listing. Sivers shares last traded at 38.00 crowns on April 30, up 815% year-to-date. The new shares would dilute ownership by about 2.5% if approved.
3 May 2026
····

Stock Market Today

  • Bipartisan Support for CLARITY Act Boosts Bitcoin and XRP in May
    May 16, 2026, 7:02 PM EDT. The CLARITY Act, which recently passed the Senate Banking Committee 15-9 with bipartisan support, sparked immediate gains in Bitcoin and XRP. Bitcoin surged to nearly $81,500, while XRP broke through $1.45 resistance briefly hitting $1.50. Historically, Bitcoin prices have rallied following significant regulatory milestones, including ETF approvals and government reserves, reaching highs of $126,000. XRP's performance is notably sensitive to regulatory clarity, exemplified by gains after an SEC ruling and classification as a digital commodity. If the CLARITY Act continues its momentum toward a Senate floor vote, both cryptocurrencies could experience further price appreciation by month-end, though Bitcoin and XRP are expected to move at different paces.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop